Skip to main content
Cardiolucent

Treatment

Chronic Heart Failure Management

Therapies

Chronic heart failure is a progressive condition in which the heart cannot meet the body's demands for blood flow, leading to fatigue, breathlessness, fluid retention, and reduced exercise capacity. Modern therapy has transformed the trajectory of heart failure — optimized guideline-directed medical therapy lowers hospitalization, slows remodeling, and extends life — but the benefit only accrues when the regimen is built, titrated, and monitored over months. Dr. Kedan provides longitudinal heart failure management at Cardiolucent: comprehensive assessment of ejection fraction and volume status, full four-pillar therapy where appropriate, device evaluation when indicated, and the close follow-up that distinguishes stability from quiet decompensation. This overview anchors the program; deeper pharmacologic detail is covered in the dedicated treatments page on ARNIs and SGLT2 inhibitors.

What This Treatment Approach Includes

  • Comprehensive heart failure evaluation: ejection fraction, biomarkers (BNP/NT-proBNP), functional class
  • Guideline-directed medical therapy with full four-pillar regimen when appropriate
  • Volume status assessment with POCUS at every office visit
  • Diuretic titration and electrolyte management for congestion control
  • Device therapy evaluation (ICD, CRT) coordinated through Cedars-Sinai when indicated
  • Cardiac rehabilitation referral and exercise prescription tailored to functional capacity
  • Direct access for weight gain, breathlessness, or symptom changes between visits

How It Works

Heart failure therapy works by blocking the neurohormonal pathways — sympathetic, renin-angiotensin-aldosterone, and natriuretic peptide systems — that drive progressive cardiac remodeling and decompensation. Layering complementary drug classes simultaneously produces a survival benefit that exceeds any single therapy, while diuretics and lifestyle measures manage symptoms in real time. Serial imaging and biomarkers confirm whether the heart is reverse-remodeling on therapy, and the regimen is adjusted as physiology changes.

Who This Is For

  • Heart failure with reduced ejection fraction (HFrEF, EF ≤ 40%)
  • Heart failure with mildly reduced ejection fraction (HFmrEF, EF 41–49%)
  • Heart failure with preserved ejection fraction (HFpEF, EF ≥ 50%)
  • Recent heart failure hospitalization or decompensation episode
  • Patients on partial therapy whose regimen has stalled below target doses
  • Cardiomyopathies of ischemic, hypertensive, valvular, or genetic origin
  • Patients evaluating advanced therapy (ICD, CRT, transplant referral) decisions

Monitoring and Follow-Up

During active titration, visits occur every two to four weeks with same-day labs to track kidney function, potassium, and blood pressure as doses advance. Once stable, the cadence relaxes but never disappears — formal echocardiograms at clinically appropriate intervals, ongoing biomarker trends, and POCUS at each visit catch subtle changes well before they become symptoms. Daily home weights remain the simplest early-warning tool, and a two- to three-pound rise over a few days triggers a direct call to Dr. Kedan rather than a wait for the next appointment.

How Cardiolucent Manages This

Heart failure outcomes hinge on whether the regimen is actually optimized — and most patients in conventional practice plateau at submaximal therapy because uptitration is logistically demanding. Cardiolucent is structured to remove that friction: extended visits for shared decision-making, same-day labs in office, coordinated communication with primary care, and direct phone access to Dr. Kedan during the titration window. When inpatient care or advanced therapies are needed, Dr. Kedan coordinates directly with the Cedars-Sinai team and stays involved as the continuity cardiologist through discharge and the high-risk weeks that follow.

Common Questions

Frequently Asked Questions

What does chronic heart failure management actually involve?
It is a long-term partnership focused on keeping your heart working as efficiently as possible and your symptoms quiet. Dr. Kedan optimizes guideline-directed medical therapy (often the four pillars known as quadruple therapy when appropriate), tracks your fluid status and functional capacity, and uses serial echocardiograms to watch how your heart is responding. Each visit is an unhurried review of how you feel, what you can do, and how the medications are working — not a five-minute medication refill.
Will I be on heart failure medications for the rest of my life?
For most patients, yes — heart failure is a chronic condition, and the medications that protect your heart generally need to be continued indefinitely to keep working. The encouraging part is that with optimized therapy, many patients see real improvement in ejection fraction and quality of life over months to years. Dr. Kedan continually reassesses your regimen as your heart remodels, and doses are titrated up or down based on how you respond, not based on a static prescription.
How will my progress be monitored?
Monitoring is hands-on and frequent. Dr. Kedan performs point-of-care ultrasound (POCUS) at every office visit to look directly at cardiac function and volume status, and orders formal echocardiograms at regular intervals to track ejection fraction and structural changes. Lab work, weight trends, blood pressure, and your reported exercise tolerance all feed into the picture — so any drift toward decompensation can be caught and corrected before it lands you in the hospital.
What side effects should I watch for on heart failure medications?
The most common ones are lightheadedness when standing, fatigue as your body adjusts to beta-blockers, and shifts in kidney function or potassium that show up on labs. SGLT2 inhibitors can cause increased urination and, rarely, urinary tract irritation. The concierge model is built for this — when something feels off, you call Dr. Kedan directly rather than waiting weeks for an appointment, and doses are adjusted in real time.
What lifestyle changes will I need to make?
Sodium moderation (typically under 2 grams per day), daily weight checks to catch fluid retention early, and consistent aerobic activity calibrated to your capacity are the foundation. Alcohol should be limited or avoided depending on your underlying etiology, and adequate sleep matters more than most patients realize. Dr. Kedan coordinates cardiac rehabilitation when appropriate and tailors the exercise prescription to your specific functional class — there is no generic plan.
Will I need a defibrillator or pacemaker?
Device therapy is considered for specific patients, generally those whose ejection fraction stays significantly reduced despite optimized medical therapy, or who meet criteria for cardiac resynchronization. The evaluation is methodical — medications are maximized first, then function is reassessed before any device discussion. If a device is indicated, Dr. Kedan coordinates the implant and follow-up through Cedars-Sinai. Schedule a consultation to discuss whether your case warrants this evaluation.
What happens if my symptoms get worse between visits?
You call directly. The concierge model means same-day access and direct physician communication, so a two-pound overnight weight gain, new shortness of breath, or worsening swelling gets addressed within hours rather than waiting for the next scheduled appointment. Often a brief diuretic adjustment over the phone prevents a hospital admission entirely.
Can I still exercise with heart failure?
In nearly all cases, yes — and you should. Regular aerobic exercise is one of the few interventions proven to improve symptoms, functional capacity, and quality of life in heart failure. Dr. Kedan builds an exercise prescription around your current capacity, often coordinating with cardiac rehabilitation to establish safe target heart rate zones. The goal is sustainable activity, not punishment.
What if I need to be hospitalized?
Cardiolucent maintains an active affiliation with Cedars-Sinai, where Dr. Kedan coordinates inpatient care directly with the hospital team. You are not handed off to a stranger — your management plan, medications, and history travel with you, and Dr. Kedan stays involved through discharge and the critical post-hospitalization period when readmission risk is highest.
How does billing work for ongoing heart failure care?
Cardiolucent does not accept Medicare or insurance and bills patients directly under a concierge model. For ongoing care like heart failure management, this means visits are as long as they need to be — typically 60+ minutes — and there is no third-party limit on how often you can be seen. We provide detailed superbills you can submit to your insurance carrier for out-of-network reimbursement. Call (310) 304-5555 to discuss the practice structure in detail.

Explore

Related Treatments

Ready to learn more about Chronic Heart Failure Management?

Schedule a private consultation with Dr. Kedan in Beverly Hills.
Schedule an Appointment

Medical Disclaimer

The information on this site is for general educational purposes only and is not medical advice, diagnosis, or treatment. Reading this site does not create a doctor–patient relationship. Always consult a qualified healthcare professional for personal guidance. If this is an emergency, call 911. Mentions of medications, devices, or procedures are informational and not endorsements. Full medical disclaimer.

†Some listed indications involve investigational/off-label use. Learn more.